Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancer
This study highlights ZDHHC9 as a potential prognostic marker, a regulator of tumor immunity, and a biomarker of therapeutic response in BC, offering a promising avenue for improving BC diagnosis and treatment.
Authors
- Haa‐Na Song (ORCID: https://orcid.org/0000-0002-7229-0153)
- Yachao Cui
- Hong Lin (ORCID: https://orcid.org/0000-0001-7336-9907)
- Desheng Zhou
- Jun Chen (ORCID: https://orcid.org/0000-0002-3439-0495)
- Zhenpeng Wu (ORCID: https://orcid.org/0009-0006-1095-0431)
- Doudou Wang
Institutions
- Guangzhou Experimental Station (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Microbiology Institute of Shaanxi (CN)
- Shaanxi Polytechnic University (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Guangzhou Medical University Cancer Hospital (CN)
- Shaanxi Yulin Energy Group (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1609621
- Citations
- 1
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.05